Rating Change
Mizuho analysts reiterated a Outperform rating on HCA Healthcare, Inc. (NYSE:HCA) on July 28, 2026.
reiterateNYSE:HCA
Mizuho Reiterates Outperform Rating on HCA Healthcare, Inc. (HCA)
Rating Change Mizuho analysts reiterated a Outperform rating on HCA Healthcare, Inc. (NYSE:HCA) on July 28, 2026. Market Context HCA Healthcare, Inc.
Market Context
HCA Healthcare, Inc. operates in the Healthcare sector. The stock currently trades at $418.19 with a market capitalization of $117.1B. The stock has declined 17.6% over the past 52 weeks.
Analyst coverage from Mizuho provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for HCA Healthcare, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for HCA Healthcare, Inc.
Among the 10 most recent ratings: 7 Buy, 2 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 28, 2026 | Goldman Sachs | Buy | N/A |
| Jul 28, 2026 | Mizuho | Outperform | N/A |
| Jul 27, 2026 | Morgan Stanley | Underweight | N/A |
| Jul 27, 2026 | UBS | Buy | N/A |
| Jul 27, 2026 | RBC Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View HCA Stock Page
Frequently Asked Questions
What does a Outperform rating mean for HCA?
A Outperform rating from Mizuho reflects the analyst's outlook on HCA Healthcare, Inc. (NYSE:HCA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HCA forecast page.
